Corporations should not have the power to undermine the global battle against Covid-19
Even if governments agree to suspend patent protections for vaccines, corporations can fight back with expensive lawsuits.
DOJ Epipen Price Gouging Deal Lacking Hundreds of Millions, Criminal Investigations
“By ending this investigation now, DOJ may forgo an effective investigation regarding the facts and scope of criminal wrongdoing.”
A last resort that might work: Small town votes in community bill of rights...
Opposing a pipeline, residents in Waterville, Ohio, passed a new law to protect their right to clean air, water, and soil.
Not Lovin’ It
McDonald's new ad campaign is trying to tap into people’s emotions linking their positive feelings of love with the Golden Arches. Maybe it would be better served to ask the workers about the “love” they’re getting from McDonald’s.
Monsanto giving cash to farmers who use controversial pesticide
Meanwhile, regulators in North Dakota, Missouri and Arkansas are taking steps to set restrictions on dicamba-based herbicides.
How Standing Rock’s divest campaign can stop future pipelines
As banks begin to respond, environmental movements are learning the importance of speaking clearly about the financial risks of fossil fuel investment.
Puerto Rico needs aid, not an occupation
Yes, Mr. President, Puerto Rico is enduring a "real catastrophe." But the U.S. military has other priorities – and that's what could make matters worse.
2.2 million petition demanding Medicare for All
Yesterday, 2.2 million petition signatures were delivered to the U.S. House of Representatives to show support of Medicare for All.
It’s our choice: Medicare for All, or endless war?
We could easily fund health care for all by ending military boondoggles and fruitless wars. Here’s how.
Ending the pandemic will take global access to COVID-19 treatment and vaccines – which...
If pharmaceutical companies don’t voluntarily help people in poor countries, those governments can do what they’ve done in past health crises: let other companies produce generic versions of patented medicines, to protect the common good.